Ma Hongxia
1. Personal Information
Title/Position: Associate professor
Correspondence Address: Department of Social Medicine and
Health Education, Nanjing Medical University, 101 Longmian Av.,
Jiangning District, Nanjing, Jiangsu Province, 211166, P.R. China.
Telephone: (86)-25-86868437
Fax: (86)-25-86868437
E-mail: mahongxia@126.com
2. Education
DEGREE (if applicable) | MM/YY | FIELD OF STUDY | |
Nanjing Medical University | B.Med. | 07/03 | Clinical Medicine |
Nanjing Medical University | M.S. | 07/06 | Epidemiology |
Nanjing Medical University | Ph.D | 07/12 | Epidemiology |
UT MD Anderson Cancer Center, Texas, USA | Visiting Scientist | 03/10 | Epidemiology |
3. Research Interests
Cancer molecular epidemiology: a) investigate biomarkers for prevention, diagnosis and prognosis of human cancer; b) clarify the biological mechanism of biomarkers in the development of cancer
4. Selected Publications
Xie K, Liang C, Li Q, Yan C, Wang C, Gu Y, Zhu M, Du F, Wang H, Dai J, Liu X, Jin G, Shen H, Ma H#, Hu Z#. Role of ATG10 expression quantitative trait loci in non-small cell lung cancer survival. Int J Cancer. 2016 Oct 1;139(7):1564-73.
Xie K*, Ma H*, Liang C, Wang C, Qin N, Shen W, Gu Y, Yan C, Zhang K, Dai N, Zhu M, Wu S, Wang H, Dai J, Jin G, Shen H, Hu Z.A functional variant in miR-155 regulation region contributes to lung cancer risk and survival.Oncotarget.2015 Dec 15;6(40):42781-92
Cao S, Wang S, Ma H#, Tang S, Sun C, Dai J, Wang C, Shu Y, Xu L, Yin R, Song X, Chen H, Han B, Li Q, Wu J, Bai C, Chen J, Jin G, Hu Z, Lu D#, Shen H#. Genome-wide association study of myelosuppression in non-small-cell lung cancer patients with platinum-based chemotherapy.Pharmacogenomics J. 2015 Mar 31. doi: 10.1038/tpj.2015.22. [Epub ahead of print]
Jin G*, Ma H*, Wu C, Dai J, Zhang R, Shi Y, Lu J, Miao X, Wang M, Zhou Y, Chen J, Li H, Pan S, Chu M, Lu F, Yu D, Jiang Y, Dong J, Hu L, Chen Y, Xu L, Shu Y, Pan S, Tan W, Zhou B, Lu D, Wu T, Zhang Z, Chen F, Wang X, Hu Z, Lin D, Shen H.Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in han chinese. Am J Hum Genet. 2012, 91(5):928-34. (*co-first author)
Ma H, Yuan H, Yuan Z, Yu C, Wang R, Jiang Y, Hu Z, Shen H, Chen N. Genetic Variations in Key MicroRNA Processing Genes and Risk of Head and Neck Cancer: A Case-Control Study in Chinese Population. PLoS One. 2012, 7(10):e47544.
Ma H, Zhou Z, Wei S, Liu Z, Pooley KA, Dunning AM, Svenson U, Roos G, Hosgood HD 3rd, Shen M, Wei Q. Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS One. 2011, 6(6):e20466.
Ma H, Yu H, Liu Z, Wang LE, Sturgis EM, Wei Q. Polymorphisms of XPG/ERCC5 and risk of squamous cell carcinoma of the head and neck. Pharmacogenet Genomics. 2012, 22(1):50-7.
Ma H, Chen J, Pan S, Dai J, Jin G, Hu Z, Shen H, Shu Y. Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population. Lung Cancer. 2011, 73(1):32-7.
Ma H, Shu Y, Pan S, Chen J, Dai J, Jin G, Hu Z, Shen H. Polymorphisms of key chemokine genes and survival of non-small cell lung cancer in Chinese. Lung Cancer. 2011, 74(2):164-9.
Ma H, Hu Z, Wang H, Jin G, Wang Y, Sun W, Chen D, Tian T, Jin L, Wei Q, Lu D, Huang W, Shen H.ERCC6/CSB gene polymorphisms and lung cancer risk. Cancer Lett. 2009, 273(1):172-6.
5. Scholarly and Professional Activities
Member, American Association for Cancer Research (AACR)
Member, Epidemiology Branch of Jiangsu Prevention Medicine Association
